BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ebrahimkhani MR, Elsharkawy AM, Mann DA. Wound healing and local neuroendocrine regulation in the injured liver. Expert Rev Mol Med. 2008;10:e11. [PMID: 18442446 DOI: 10.1017/S146239940800063X] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Bona S, Filippin LI, Di Naso FC, de David C, Valiatti B, Isoppo Schaun M, Xavier RM, Marroni NP. Effect of antioxidant treatment on fibrogenesis in rats with carbon tetrachloride-induced cirrhosis. ISRN Gastroenterol. 2012;2012:762920. [PMID: 22577570 DOI: 10.5402/2012/762920] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
2 Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7:425-436. [PMID: 20585339 DOI: 10.1038/nrgastro. 2010.97] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology. 2010;138:705-714, 714.e1-714.e4. [PMID: 19843474 DOI: 10.1053/j.gastro.2009.10.002] [Cited by in Crossref: 264] [Cited by in F6Publishing: 272] [Article Influence: 20.3] [Reference Citation Analysis]
4 Hajiasgharzadeh K, Baradaran B. Cholinergic Anti-Inflammatory Pathway and the Liver. Adv Pharm Bull 2017;7:507-13. [PMID: 29399541 DOI: 10.15171/apb.2017.063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
5 Glaser SS, Gaudio E, Miller T, Alvaro D, Alpini G. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med. 2009;11:e7. [PMID: 19239726 DOI: 10.1017/s1462399409000994] [Cited by in Crossref: 123] [Cited by in F6Publishing: 74] [Article Influence: 9.5] [Reference Citation Analysis]
6 Li S. Role of the renin-angiotensin system in liver fibrosis. Shijie Huaren Xiaohua Zazhi 2013; 21(22): 2151-2157 [DOI: 10.11569/wcjd.v21.i22.2151] [Reference Citation Analysis]
7 Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425-36. [DOI: 10.1038/nrgastro.2010.97] [Cited by in Crossref: 377] [Cited by in F6Publishing: 379] [Article Influence: 31.4] [Reference Citation Analysis]
8 Ebrahimkhani MR, Neiman JA, Raredon MS, Hughes DJ, Griffith LG. Bioreactor technologies to support liver function in vitro. Adv Drug Deliv Rev 2014;69-70:132-57. [PMID: 24607703 DOI: 10.1016/j.addr.2014.02.011] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 12.5] [Reference Citation Analysis]